MX2007002271A - Terapia anticancer combinada y composiciones farmaceuticas para la misma. - Google Patents
Terapia anticancer combinada y composiciones farmaceuticas para la misma.Info
- Publication number
- MX2007002271A MX2007002271A MX2007002271A MX2007002271A MX2007002271A MX 2007002271 A MX2007002271 A MX 2007002271A MX 2007002271 A MX2007002271 A MX 2007002271A MX 2007002271 A MX2007002271 A MX 2007002271A MX 2007002271 A MX2007002271 A MX 2007002271A
- Authority
- MX
- Mexico
- Prior art keywords
- relates
- pharmaceutical compositions
- anticancer therapy
- cancer
- general formula
- Prior art date
Links
- 238000011319 anticancer therapy Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 3
- 201000011510 cancer Diseases 0.000 abstract 3
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000002168 alkylating agent Substances 0.000 abstract 1
- 229940100198 alkylating agent Drugs 0.000 abstract 1
- 230000000118 anti-neoplastic effect Effects 0.000 abstract 1
- 239000002256 antimetabolite Substances 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940127089 cytotoxic agent Drugs 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 230000001900 immune effect Effects 0.000 abstract 1
- 239000003022 immunostimulating agent Substances 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 150000007530 organic bases Chemical class 0.000 abstract 1
- 238000001959 radiotherapy Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 210000005239 tubule Anatomy 0.000 abstract 1
- 229940121358 tyrosine kinase inhibitor Drugs 0.000 abstract 1
- 239000005483 tyrosine kinase inhibitor Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Esta invencion se relaciona con la terapia anticancer, y de manera mas precisa, con el control inmunologico del cancer. Especificamente esta invencion se relaciona con composiciones farmaceuticas que incorporan como el agente activo al menos un agente inmunoestimulante con grupos cargados o centrales de formula general (I), donde X, Y, A, B, R1 y R2 son como se definen en la especificacion junto con un metodo de radioterapia adecuado para combatir el cancer o junto con un agente quimioterapeutico seleccionado del grupo que consiste de agentes alquilante, agentes antimetabolicos, agentes que actuan sobre los tumulos e inhibidores de tirosina Cinasa en conjunto o en mezcla con un diluente o soporte farmaceuticamente aceptable no toxico. Esta invencion tambien se relaciona con las sales de un compuesto de formula general (I) con una base mineral u organica, es decir una base farmaceuticamente aceptable. El uso para tratar condiciones cancerosas dentro de un solo recipiente o contenido dentro de distintos recipientes.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IB2004002378 | 2004-07-23 | ||
| PCT/IB2005/000944 WO2006011007A1 (en) | 2004-07-23 | 2005-03-10 | Combination anticancer therapy and pharmaceutical compositions therefore |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2007002271A true MX2007002271A (es) | 2007-06-15 |
Family
ID=34958692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2007002271A MX2007002271A (es) | 2004-07-23 | 2005-03-10 | Terapia anticancer combinada y composiciones farmaceuticas para la misma. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20090214669A1 (es) |
| EP (2) | EP1773318A1 (es) |
| JP (1) | JP2008507499A (es) |
| KR (1) | KR20070065311A (es) |
| AU (1) | AU2005266106B2 (es) |
| CA (1) | CA2587019A1 (es) |
| MX (1) | MX2007002271A (es) |
| RU (1) | RU2396960C2 (es) |
| WO (1) | WO2006011007A1 (es) |
| ZA (1) | ZA200701578B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006011007A1 (en) * | 2004-07-23 | 2006-02-02 | Om Pharma | Combination anticancer therapy and pharmaceutical compositions therefore |
| KR101726282B1 (ko) * | 2008-08-15 | 2017-04-12 | 더 유에이비 리서치 파운데이션 | 뉴클레오시드 프로드럭의 효소 활성자로서의 퓨린 뉴클레오시드 인산화효소 |
| RS54233B1 (sr) * | 2008-08-25 | 2015-12-31 | Amplimmune Inc. | Kompozicije pd-1 antagonista i postupci za njihovu primenu |
| US8357652B2 (en) | 2009-11-20 | 2013-01-22 | Academia Sinica | Anti-tumor fibrillar human serum albumin methods and compositions |
| UA98665C2 (ru) * | 2010-03-25 | 2012-06-11 | Геннадий Васильевич Мазильников | Лекарственный препарат, проявляющий противоопухолевое действие в отношении злокачественных клеток, и способ лечения |
| UA98666C2 (ru) * | 2010-03-25 | 2012-06-11 | Геннадий Васильевич Мазильников | Лекарственный препарат на основе щавелевой кислоты, проявляющий противоопухолевое действие в отношении злокачественных клеток, и способ лечения |
| US10585101B2 (en) * | 2016-03-10 | 2020-03-10 | Wavesense, Inc. | Prostatic liquid biopsy for the detection of prostate cancer and benign prostatic hyperplasia |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3443507A1 (de) * | 1984-11-29 | 1986-06-12 | Mückter, Heinrich, Dipl.-Chem. Dr., 5100 Aachen | Verwendung von gereinigten lipopolysacchariden und deren derivaten |
| GR860379B (en) * | 1985-02-22 | 1986-06-11 | Akzo Nv | Novel disaccharide and trisaccharide derivatives of the lipid a type |
| US4912094B1 (en) * | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
| EP0668289A4 (en) * | 1993-09-07 | 1998-10-21 | Suntory Ltd | NEW DISACCHARIDE DERIVATIVE. |
| AU700485B2 (en) * | 1993-11-17 | 1999-01-07 | Om Pharma | Glucosamine disaccharides, method for their preparation, pharmaceutical composition comprising same, and their use |
| WO2001046127A1 (fr) * | 1999-12-22 | 2001-06-28 | Om Pharma | Pseudodipeptides acyles porteurs d'un bras auxiliaire fonctionnalise |
| US20020156033A1 (en) * | 2000-03-03 | 2002-10-24 | Bratzler Robert L. | Immunostimulatory nucleic acids and cancer medicament combination therapy for the treatment of cancer |
| EP1488381A2 (en) * | 2002-03-18 | 2004-12-22 | Koninklijke Philips Electronics N.V. | Holder for papers of value, and method of registering the contents thereof |
| WO2006011007A1 (en) * | 2004-07-23 | 2006-02-02 | Om Pharma | Combination anticancer therapy and pharmaceutical compositions therefore |
-
2005
- 2005-03-10 WO PCT/IB2005/000944 patent/WO2006011007A1/en not_active Ceased
- 2005-03-10 ZA ZA200701578A patent/ZA200701578B/xx unknown
- 2005-03-10 RU RU2007106845/15A patent/RU2396960C2/ru not_active IP Right Cessation
- 2005-03-10 JP JP2007522042A patent/JP2008507499A/ja active Pending
- 2005-03-10 KR KR1020077004436A patent/KR20070065311A/ko not_active Ceased
- 2005-03-10 AU AU2005266106A patent/AU2005266106B2/en not_active Ceased
- 2005-03-10 MX MX2007002271A patent/MX2007002271A/es active IP Right Grant
- 2005-03-10 EP EP05718408A patent/EP1773318A1/en not_active Withdrawn
- 2005-03-10 CA CA002587019A patent/CA2587019A1/en not_active Abandoned
- 2005-07-23 US US11/658,384 patent/US20090214669A1/en not_active Abandoned
-
2006
- 2006-03-03 EP EP06744661A patent/EP2170318A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CA2587019A1 (en) | 2006-02-02 |
| EP1773318A1 (en) | 2007-04-18 |
| WO2006011007A1 (en) | 2006-02-02 |
| US20090214669A1 (en) | 2009-08-27 |
| AU2005266106B2 (en) | 2010-12-09 |
| AU2005266106A1 (en) | 2006-02-02 |
| EP2170318A1 (en) | 2010-04-07 |
| KR20070065311A (ko) | 2007-06-22 |
| JP2008507499A (ja) | 2008-03-13 |
| RU2396960C2 (ru) | 2010-08-20 |
| RU2007106845A (ru) | 2008-09-10 |
| ZA200701578B (en) | 2008-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1277754B8 (en) | Imidazopyridine derivatives | |
| UA83091C2 (en) | Pyrido[2,3-d]pyrimidine-2,4-diamines as pde 2 inhibitors | |
| MY141739A (en) | Substituted quinazoline derivatives as inhibitors of aurora kinases | |
| MXPA05013142A (es) | Compuestos de piridinio [1,2-a]pirimidin-4-ona como agentes anticancer. | |
| MXPA05007352A (es) | Compuestos triciclicos inhibidores de proteina quinasa para mejorar la eficacia de agentes antineoplasicos y terapia de radiacion. | |
| MY189118A (en) | Pyrazolo[1,5-a]pyrazin-4-yl derivatives | |
| WO2004096131A3 (en) | Inhibitors of akt activity | |
| WO2004096135A3 (en) | Inhibitors of akt activity | |
| TR200102911T2 (tr) | Adamantan türevleri. | |
| WO2006067614A3 (en) | Heteroaromatic derivatives useful as anticancer agents | |
| CA2480800A1 (en) | Inhibitors of akt activity | |
| TW200517106A (en) | Sustained release pharmaceutical compositions | |
| TW200800990A (en) | Azaindole inhibitors of aurora kinases | |
| AU2003228770A1 (en) | Substituted pyrazolopyrimidines | |
| MXPA05008690A (es) | Derivados de adamantano, procedimientos para su preparacion y composiciones farmaceuticas que los contienen. | |
| MXPA04004606A (es) | Venenos de topoisomerasa solubilizados. | |
| UA95257C2 (ru) | 1-азабициклоалкилпроизводные для лечения психических расстройств | |
| WO2004076445A3 (en) | Compounds and methods of treating cell proliferative diseases, retinopathies and arthritis | |
| IL137964A0 (en) | Antitumor agents | |
| MX2007002271A (es) | Terapia anticancer combinada y composiciones farmaceuticas para la misma. | |
| UA90285C2 (ru) | Производные гидантоина, полезные как ингибиторы металлопротеиназ | |
| AU2002364953A8 (en) | Topoisomerase poison agents | |
| WO2003051289A3 (en) | Solubilized topoisomerase poison agents | |
| WO2007120333A3 (en) | Tetracyclic kinase inhibitors | |
| MXPA05010783A (es) | Derivados antimicrobianos de [3.1.0] biciclohexilfenil-oxazolidinona y analogos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |